Table of contents

February 2018 - Volume 3 - 2


A

  1. Aiba, Keisuke

    1. Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations
      Satoshi Oizumi, Shunichi Sugawara, Koichi Minato, Toshiyuki Harada, Akira Inoue, Yuka Fujita, Makoto Maemondo, Satoshi Watanabe, Kazuhiko Ito, Akihiko Gemma, Yoshiki Demura, Shinichi Fukumoto, Hiroshi Isobe, Ichiro Kinoshita, Satoshi Morita, Kunihiko Kobayashi, Koichi Hagiwara, Keisuke Aiba, Toshihiro Nukiwa
  2. Aogi, Kenjiro

    1. Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial
      Takayuki Ueno, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Takeharu Yamanaka, Hironobu Sasano, Masakazu Toi

B

  1. Baba, Eishi

    1. Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan
      Taro Funakoshi, Takahiro Horimatsu, Michio Nakamura, Koichi Shiroshita, Koichi Suyama, Masashi Mukoyama, Takuro Mizukami, Tsutomu Sakurada, Eishi Baba, Kazuhiko Tsuruya, Akira Nozaki, Kensei Yahata, Yukinori Ozaki, Yoshifumi Ubara, Hisateru Yasui, Akihiro Yoshimoto, Shingo Fukuma, Naoya Kondo, Takeshi Matsubara, Kazuo Matsubara, Shunichi Fukuhara, Motoko Yanagita, Manabu Muto
  2. Banerjee, Susana

    1. Global cancer control: responding to the growing burden, rising costs and inequalities in access
      Gerald W Prager, Sofia Braga, Branislav Bystricky, Camilla Qvortrup, Carmen Criscitiello, Ece Esin, Gabe S Sonke, Guillem Argilés Martínez, Jean-Sebastian Frenel, Michalis Karamouzis, Michiel Strijbos, Ozan Yazici, Paolo Bossi, Susana Banerjee, Teresa Troiani, Alexandru Eniu, Fortunato Ciardiello, Josep Tabernero, Christoph C Zielinski, Paolo G Casali, Fatima Cardoso, Jean-Yves Douillard, Svetlana Jezdic, Keith McGregor, Gracemarie Bricalli, Malvika Vyas, André Ilbawi
  3. Barker, Claire

    1. Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanoma
      Kok Haw Jonathan Lim, Lavinia Spain, Claire Barker, Alexandros Georgiou, Gerard Walls, Martin Gore, Samra Turajlic, Ruth Board, James M Larkin, Paul Lorigan
  4. Bauer, Todd M

    1. Phase I study of the investigational oral mTORC1/2 inhibitor sapanisertib (TAK-228): tolerability and food effects of a milled formulation in patients with advanced solid tumours
      Kathleen N Moore, Todd M Bauer, Gerald S Falchook, Swapan Chowdhury, Chirag Patel, Rachel Neuwirth, Aaron Enke, Fabian Zohren, Manish R Patel
  5. Baumeister, Hans

    1. Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas
      Walter Fiedler, Sara Cresta, Henning Schulze-Bergkamen, Sara De Dosso, Jens Weidmann, Anna Tessari, Hans Baumeister, Antje Danielczyk, Bruno Dietrich, Steffen Goletz, Alfredo Zurlo, Marc Salzberg, Cristiana Sessa, Luca Gianni
  6. Board, Ruth

    1. Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanoma
      Kok Haw Jonathan Lim, Lavinia Spain, Claire Barker, Alexandros Georgiou, Gerard Walls, Martin Gore, Samra Turajlic, Ruth Board, James M Larkin, Paul Lorigan
  7. Bossi, Paolo

    1. Global cancer control: responding to the growing burden, rising costs and inequalities in access
      Gerald W Prager, Sofia Braga, Branislav Bystricky, Camilla Qvortrup, Carmen Criscitiello, Ece Esin, Gabe S Sonke, Guillem Argilés Martínez, Jean-Sebastian Frenel, Michalis Karamouzis, Michiel Strijbos, Ozan Yazici, Paolo Bossi, Susana Banerjee, Teresa Troiani, Alexandru Eniu, Fortunato Ciardiello, Josep Tabernero, Christoph C Zielinski, Paolo G Casali, Fatima Cardoso, Jean-Yves Douillard, Svetlana Jezdic, Keith McGregor, Gracemarie Bricalli, Malvika Vyas, André Ilbawi
  8. Braga, Sofia

    1. Global cancer control: responding to the growing burden, rising costs and inequalities in access
      Gerald W Prager, Sofia Braga, Branislav Bystricky, Camilla Qvortrup, Carmen Criscitiello, Ece Esin, Gabe S Sonke, Guillem Argilés Martínez, Jean-Sebastian Frenel, Michalis Karamouzis, Michiel Strijbos, Ozan Yazici, Paolo Bossi, Susana Banerjee, Teresa Troiani, Alexandru Eniu, Fortunato Ciardiello, Josep Tabernero, Christoph C Zielinski, Paolo G Casali, Fatima Cardoso, Jean-Yves Douillard, Svetlana Jezdic, Keith McGregor, Gracemarie Bricalli, Malvika Vyas, André Ilbawi
  9. Bricalli, Gracemarie

    1. Global cancer control: responding to the growing burden, rising costs and inequalities in access
      Gerald W Prager, Sofia Braga, Branislav Bystricky, Camilla Qvortrup, Carmen Criscitiello, Ece Esin, Gabe S Sonke, Guillem Argilés Martínez, Jean-Sebastian Frenel, Michalis Karamouzis, Michiel Strijbos, Ozan Yazici, Paolo Bossi, Susana Banerjee, Teresa Troiani, Alexandru Eniu, Fortunato Ciardiello, Josep Tabernero, Christoph C Zielinski, Paolo G Casali, Fatima Cardoso, Jean-Yves Douillard, Svetlana Jezdic, Keith McGregor, Gracemarie Bricalli, Malvika Vyas, André Ilbawi
  10. Bystricky, Branislav

    1. Global cancer control: responding to the growing burden, rising costs and inequalities in access
      Gerald W Prager, Sofia Braga, Branislav Bystricky, Camilla Qvortrup, Carmen Criscitiello, Ece Esin, Gabe S Sonke, Guillem Argilés Martínez, Jean-Sebastian Frenel, Michalis Karamouzis, Michiel Strijbos, Ozan Yazici, Paolo Bossi, Susana Banerjee, Teresa Troiani, Alexandru Eniu, Fortunato Ciardiello, Josep Tabernero, Christoph C Zielinski, Paolo G Casali, Fatima Cardoso, Jean-Yves Douillard, Svetlana Jezdic, Keith McGregor, Gracemarie Bricalli, Malvika Vyas, André Ilbawi

C

  1. Cardoso, Fatima

    1. Global cancer control: responding to the growing burden, rising costs and inequalities in access
      Gerald W Prager, Sofia Braga, Branislav Bystricky, Camilla Qvortrup, Carmen Criscitiello, Ece Esin, Gabe S Sonke, Guillem Argilés Martínez, Jean-Sebastian Frenel, Michalis Karamouzis, Michiel Strijbos, Ozan Yazici, Paolo Bossi, Susana Banerjee, Teresa Troiani, Alexandru Eniu, Fortunato Ciardiello, Josep Tabernero, Christoph C Zielinski, Paolo G Casali, Fatima Cardoso, Jean-Yves Douillard, Svetlana Jezdic, Keith McGregor, Gracemarie Bricalli, Malvika Vyas, André Ilbawi
  2. Casali, Paolo G

    1. Global cancer control: responding to the growing burden, rising costs and inequalities in access
      Gerald W Prager, Sofia Braga, Branislav Bystricky, Camilla Qvortrup, Carmen Criscitiello, Ece Esin, Gabe S Sonke, Guillem Argilés Martínez, Jean-Sebastian Frenel, Michalis Karamouzis, Michiel Strijbos, Ozan Yazici, Paolo Bossi, Susana Banerjee, Teresa Troiani, Alexandru Eniu, Fortunato Ciardiello, Josep Tabernero, Christoph C Zielinski, Paolo G Casali, Fatima Cardoso, Jean-Yves Douillard, Svetlana Jezdic, Keith McGregor, Gracemarie Bricalli, Malvika Vyas, André Ilbawi
  3. Cervantes, Andrés

    1. In the literature: February 2018
      Andrés Cervantes
  4. Chowdhury, Swapan

    1. Phase I study of the investigational oral mTORC1/2 inhibitor sapanisertib (TAK-228): tolerability and food effects of a milled formulation in patients with advanced solid tumours
      Kathleen N Moore, Todd M Bauer, Gerald S Falchook, Swapan Chowdhury, Chirag Patel, Rachel Neuwirth, Aaron Enke, Fabian Zohren, Manish R Patel
  5. Ciardiello, Fortunato

    1. Global cancer control: responding to the growing burden, rising costs and inequalities in access
      Gerald W Prager, Sofia Braga, Branislav Bystricky, Camilla Qvortrup, Carmen Criscitiello, Ece Esin, Gabe S Sonke, Guillem Argilés Martínez, Jean-Sebastian Frenel, Michalis Karamouzis, Michiel Strijbos, Ozan Yazici, Paolo Bossi, Susana Banerjee, Teresa Troiani, Alexandru Eniu, Fortunato Ciardiello, Josep Tabernero, Christoph C Zielinski, Paolo G Casali, Fatima Cardoso, Jean-Yves Douillard, Svetlana Jezdic, Keith McGregor, Gracemarie Bricalli, Malvika Vyas, André Ilbawi
  6. Clarke, Stephen J

    1. Prognostic indices of inflammatory markers, cognitive function and fatigue for survival in patients with localised colorectal cancer
      Janette L Vardy, Haryana Mary Dhillon, Gregory R Pond, Corrinne Renton, Stephen J Clarke, Ian F Tannock
  7. Cresta, Sara

    1. Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas
      Walter Fiedler, Sara Cresta, Henning Schulze-Bergkamen, Sara De Dosso, Jens Weidmann, Anna Tessari, Hans Baumeister, Antje Danielczyk, Bruno Dietrich, Steffen Goletz, Alfredo Zurlo, Marc Salzberg, Cristiana Sessa, Luca Gianni
  8. Criscitiello, Carmen

    1. Global cancer control: responding to the growing burden, rising costs and inequalities in access
      Gerald W Prager, Sofia Braga, Branislav Bystricky, Camilla Qvortrup, Carmen Criscitiello, Ece Esin, Gabe S Sonke, Guillem Argilés Martínez, Jean-Sebastian Frenel, Michalis Karamouzis, Michiel Strijbos, Ozan Yazici, Paolo Bossi, Susana Banerjee, Teresa Troiani, Alexandru Eniu, Fortunato Ciardiello, Josep Tabernero, Christoph C Zielinski, Paolo G Casali, Fatima Cardoso, Jean-Yves Douillard, Svetlana Jezdic, Keith McGregor, Gracemarie Bricalli, Malvika Vyas, André Ilbawi

D

  1. Danielczyk, Antje

    1. Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas
      Walter Fiedler, Sara Cresta, Henning Schulze-Bergkamen, Sara De Dosso, Jens Weidmann, Anna Tessari, Hans Baumeister, Antje Danielczyk, Bruno Dietrich, Steffen Goletz, Alfredo Zurlo, Marc Salzberg, Cristiana Sessa, Luca Gianni
  2. De Dosso, Sara

    1. Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas
      Walter Fiedler, Sara Cresta, Henning Schulze-Bergkamen, Sara De Dosso, Jens Weidmann, Anna Tessari, Hans Baumeister, Antje Danielczyk, Bruno Dietrich, Steffen Goletz, Alfredo Zurlo, Marc Salzberg, Cristiana Sessa, Luca Gianni
  3. Demonty, Gaston

    1. Exploratory pooled analysis evaluating the effect of sequence of biological therapies on overall survival in patients with RAS wild-type metastatic colorectal carcinoma
      Marc Peeters, Frédéric Forget, Meinolf Karthaus, Manuel Valladares-Ayerbes, Alberto Zaniboni, Gaston Demonty, Xuesong Guan, Fernando Rivera
  4. Demura, Yoshiki

    1. Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations
      Satoshi Oizumi, Shunichi Sugawara, Koichi Minato, Toshiyuki Harada, Akira Inoue, Yuka Fujita, Makoto Maemondo, Satoshi Watanabe, Kazuhiko Ito, Akihiko Gemma, Yoshiki Demura, Shinichi Fukumoto, Hiroshi Isobe, Ichiro Kinoshita, Satoshi Morita, Kunihiko Kobayashi, Koichi Hagiwara, Keisuke Aiba, Toshihiro Nukiwa
  5. Dhillon, Haryana Mary

    1. Prognostic indices of inflammatory markers, cognitive function and fatigue for survival in patients with localised colorectal cancer
      Janette L Vardy, Haryana Mary Dhillon, Gregory R Pond, Corrinne Renton, Stephen J Clarke, Ian F Tannock
  6. Dietrich, Bruno

    1. Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas
      Walter Fiedler, Sara Cresta, Henning Schulze-Bergkamen, Sara De Dosso, Jens Weidmann, Anna Tessari, Hans Baumeister, Antje Danielczyk, Bruno Dietrich, Steffen Goletz, Alfredo Zurlo, Marc Salzberg, Cristiana Sessa, Luca Gianni
  7. Douillard, Jean-Yves

    1. Global cancer control: responding to the growing burden, rising costs and inequalities in access
      Gerald W Prager, Sofia Braga, Branislav Bystricky, Camilla Qvortrup, Carmen Criscitiello, Ece Esin, Gabe S Sonke, Guillem Argilés Martínez, Jean-Sebastian Frenel, Michalis Karamouzis, Michiel Strijbos, Ozan Yazici, Paolo Bossi, Susana Banerjee, Teresa Troiani, Alexandru Eniu, Fortunato Ciardiello, Josep Tabernero, Christoph C Zielinski, Paolo G Casali, Fatima Cardoso, Jean-Yves Douillard, Svetlana Jezdic, Keith McGregor, Gracemarie Bricalli, Malvika Vyas, André Ilbawi

E

  1. Eniu, Alexandru

    1. Global cancer control: responding to the growing burden, rising costs and inequalities in access
      Gerald W Prager, Sofia Braga, Branislav Bystricky, Camilla Qvortrup, Carmen Criscitiello, Ece Esin, Gabe S Sonke, Guillem Argilés Martínez, Jean-Sebastian Frenel, Michalis Karamouzis, Michiel Strijbos, Ozan Yazici, Paolo Bossi, Susana Banerjee, Teresa Troiani, Alexandru Eniu, Fortunato Ciardiello, Josep Tabernero, Christoph C Zielinski, Paolo G Casali, Fatima Cardoso, Jean-Yves Douillard, Svetlana Jezdic, Keith McGregor, Gracemarie Bricalli, Malvika Vyas, André Ilbawi
  2. Enke, Aaron

    1. Phase I study of the investigational oral mTORC1/2 inhibitor sapanisertib (TAK-228): tolerability and food effects of a milled formulation in patients with advanced solid tumours
      Kathleen N Moore, Todd M Bauer, Gerald S Falchook, Swapan Chowdhury, Chirag Patel, Rachel Neuwirth, Aaron Enke, Fabian Zohren, Manish R Patel
  3. Esin, Ece

    1. Global cancer control: responding to the growing burden, rising costs and inequalities in access
      Gerald W Prager, Sofia Braga, Branislav Bystricky, Camilla Qvortrup, Carmen Criscitiello, Ece Esin, Gabe S Sonke, Guillem Argilés Martínez, Jean-Sebastian Frenel, Michalis Karamouzis, Michiel Strijbos, Ozan Yazici, Paolo Bossi, Susana Banerjee, Teresa Troiani, Alexandru Eniu, Fortunato Ciardiello, Josep Tabernero, Christoph C Zielinski, Paolo G Casali, Fatima Cardoso, Jean-Yves Douillard, Svetlana Jezdic, Keith McGregor, Gracemarie Bricalli, Malvika Vyas, André Ilbawi

F

  1. Falchook, Gerald S

    1. Phase I study of the investigational oral mTORC1/2 inhibitor sapanisertib (TAK-228): tolerability and food effects of a milled formulation in patients with advanced solid tumours
      Kathleen N Moore, Todd M Bauer, Gerald S Falchook, Swapan Chowdhury, Chirag Patel, Rachel Neuwirth, Aaron Enke, Fabian Zohren, Manish R Patel
  2. Fiedler, Walter

    1. Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas
      Walter Fiedler, Sara Cresta, Henning Schulze-Bergkamen, Sara De Dosso, Jens Weidmann, Anna Tessari, Hans Baumeister, Antje Danielczyk, Bruno Dietrich, Steffen Goletz, Alfredo Zurlo, Marc Salzberg, Cristiana Sessa, Luca Gianni
  3. Forget, Frédéric

    1. Exploratory pooled analysis evaluating the effect of sequence of biological therapies on overall survival in patients with RAS wild-type metastatic colorectal carcinoma
      Marc Peeters, Frédéric Forget, Meinolf Karthaus, Manuel Valladares-Ayerbes, Alberto Zaniboni, Gaston Demonty, Xuesong Guan, Fernando Rivera
  4. Frenel, Jean-Sebastian

    1. Global cancer control: responding to the growing burden, rising costs and inequalities in access
      Gerald W Prager, Sofia Braga, Branislav Bystricky, Camilla Qvortrup, Carmen Criscitiello, Ece Esin, Gabe S Sonke, Guillem Argilés Martínez, Jean-Sebastian Frenel, Michalis Karamouzis, Michiel Strijbos, Ozan Yazici, Paolo Bossi, Susana Banerjee, Teresa Troiani, Alexandru Eniu, Fortunato Ciardiello, Josep Tabernero, Christoph C Zielinski, Paolo G Casali, Fatima Cardoso, Jean-Yves Douillard, Svetlana Jezdic, Keith McGregor, Gracemarie Bricalli, Malvika Vyas, André Ilbawi
  5. Fujita, Yuka

    1. Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations
      Satoshi Oizumi, Shunichi Sugawara, Koichi Minato, Toshiyuki Harada, Akira Inoue, Yuka Fujita, Makoto Maemondo, Satoshi Watanabe, Kazuhiko Ito, Akihiko Gemma, Yoshiki Demura, Shinichi Fukumoto, Hiroshi Isobe, Ichiro Kinoshita, Satoshi Morita, Kunihiko Kobayashi, Koichi Hagiwara, Keisuke Aiba, Toshihiro Nukiwa
  6. Fujiwara, Yutaka

    1. Circulating cell-free plasma tumour DNA shows a higher incidence of EGFR mutations in patients with extrathoracic disease progression
      Yoshitaka Seki, Yutaka Fujiwara, Takashi Kohno, Kazushi Yoshida, Yasushi Goto, Hidehito Horinouchi, Shintaro Kanda, Hiroshi Nokihara, Noboru Yamamoto, Kazuyoshi Kuwano, Yuichiro Ohe
  7. Fukuhara, Shunichi

    1. Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan
      Taro Funakoshi, Takahiro Horimatsu, Michio Nakamura, Koichi Shiroshita, Koichi Suyama, Masashi Mukoyama, Takuro Mizukami, Tsutomu Sakurada, Eishi Baba, Kazuhiko Tsuruya, Akira Nozaki, Kensei Yahata, Yukinori Ozaki, Yoshifumi Ubara, Hisateru Yasui, Akihiro Yoshimoto, Shingo Fukuma, Naoya Kondo, Takeshi Matsubara, Kazuo Matsubara, Shunichi Fukuhara, Motoko Yanagita, Manabu Muto
  8. Fukuma, Shingo

    1. Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan
      Taro Funakoshi, Takahiro Horimatsu, Michio Nakamura, Koichi Shiroshita, Koichi Suyama, Masashi Mukoyama, Takuro Mizukami, Tsutomu Sakurada, Eishi Baba, Kazuhiko Tsuruya, Akira Nozaki, Kensei Yahata, Yukinori Ozaki, Yoshifumi Ubara, Hisateru Yasui, Akihiro Yoshimoto, Shingo Fukuma, Naoya Kondo, Takeshi Matsubara, Kazuo Matsubara, Shunichi Fukuhara, Motoko Yanagita, Manabu Muto
  9. Fukumoto, Shinichi

    1. Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations
      Satoshi Oizumi, Shunichi Sugawara, Koichi Minato, Toshiyuki Harada, Akira Inoue, Yuka Fujita, Makoto Maemondo, Satoshi Watanabe, Kazuhiko Ito, Akihiko Gemma, Yoshiki Demura, Shinichi Fukumoto, Hiroshi Isobe, Ichiro Kinoshita, Satoshi Morita, Kunihiko Kobayashi, Koichi Hagiwara, Keisuke Aiba, Toshihiro Nukiwa
  10. Funakoshi, Taro

    1. Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan
      Taro Funakoshi, Takahiro Horimatsu, Michio Nakamura, Koichi Shiroshita, Koichi Suyama, Masashi Mukoyama, Takuro Mizukami, Tsutomu Sakurada, Eishi Baba, Kazuhiko Tsuruya, Akira Nozaki, Kensei Yahata, Yukinori Ozaki, Yoshifumi Ubara, Hisateru Yasui, Akihiro Yoshimoto, Shingo Fukuma, Naoya Kondo, Takeshi Matsubara, Kazuo Matsubara, Shunichi Fukuhara, Motoko Yanagita, Manabu Muto

G

  1. Gemma, Akihiko

    1. Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations
      Satoshi Oizumi, Shunichi Sugawara, Koichi Minato, Toshiyuki Harada, Akira Inoue, Yuka Fujita, Makoto Maemondo, Satoshi Watanabe, Kazuhiko Ito, Akihiko Gemma, Yoshiki Demura, Shinichi Fukumoto, Hiroshi Isobe, Ichiro Kinoshita, Satoshi Morita, Kunihiko Kobayashi, Koichi Hagiwara, Keisuke Aiba, Toshihiro Nukiwa
  2. Georgiou, Alexandros

    1. Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanoma
      Kok Haw Jonathan Lim, Lavinia Spain, Claire Barker, Alexandros Georgiou, Gerard Walls, Martin Gore, Samra Turajlic, Ruth Board, James M Larkin, Paul Lorigan
  3. Gianni, Luca

    1. Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas
      Walter Fiedler, Sara Cresta, Henning Schulze-Bergkamen, Sara De Dosso, Jens Weidmann, Anna Tessari, Hans Baumeister, Antje Danielczyk, Bruno Dietrich, Steffen Goletz, Alfredo Zurlo, Marc Salzberg, Cristiana Sessa, Luca Gianni
  4. Goletz, Steffen

    1. Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas
      Walter Fiedler, Sara Cresta, Henning Schulze-Bergkamen, Sara De Dosso, Jens Weidmann, Anna Tessari, Hans Baumeister, Antje Danielczyk, Bruno Dietrich, Steffen Goletz, Alfredo Zurlo, Marc Salzberg, Cristiana Sessa, Luca Gianni
  5. Gore, Martin

    1. Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanoma
      Kok Haw Jonathan Lim, Lavinia Spain, Claire Barker, Alexandros Georgiou, Gerard Walls, Martin Gore, Samra Turajlic, Ruth Board, James M Larkin, Paul Lorigan
  6. Goto, Yasushi

    1. Circulating cell-free plasma tumour DNA shows a higher incidence of EGFR mutations in patients with extrathoracic disease progression
      Yoshitaka Seki, Yutaka Fujiwara, Takashi Kohno, Kazushi Yoshida, Yasushi Goto, Hidehito Horinouchi, Shintaro Kanda, Hiroshi Nokihara, Noboru Yamamoto, Kazuyoshi Kuwano, Yuichiro Ohe
  7. Guan, Xuesong

    1. Exploratory pooled analysis evaluating the effect of sequence of biological therapies on overall survival in patients with RAS wild-type metastatic colorectal carcinoma
      Marc Peeters, Frédéric Forget, Meinolf Karthaus, Manuel Valladares-Ayerbes, Alberto Zaniboni, Gaston Demonty, Xuesong Guan, Fernando Rivera

H

  1. Hagiwara, Koichi

    1. Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations
      Satoshi Oizumi, Shunichi Sugawara, Koichi Minato, Toshiyuki Harada, Akira Inoue, Yuka Fujita, Makoto Maemondo, Satoshi Watanabe, Kazuhiko Ito, Akihiko Gemma, Yoshiki Demura, Shinichi Fukumoto, Hiroshi Isobe, Ichiro Kinoshita, Satoshi Morita, Kunihiko Kobayashi, Koichi Hagiwara, Keisuke Aiba, Toshihiro Nukiwa
  2. Harada, Toshiyuki

    1. Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations
      Satoshi Oizumi, Shunichi Sugawara, Koichi Minato, Toshiyuki Harada, Akira Inoue, Yuka Fujita, Makoto Maemondo, Satoshi Watanabe, Kazuhiko Ito, Akihiko Gemma, Yoshiki Demura, Shinichi Fukumoto, Hiroshi Isobe, Ichiro Kinoshita, Satoshi Morita, Kunihiko Kobayashi, Koichi Hagiwara, Keisuke Aiba, Toshihiro Nukiwa
  3. Hisamatsu, Kazufumi

    1. Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial
      Takayuki Ueno, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Takeharu Yamanaka, Hironobu Sasano, Masakazu Toi
  4. Horimatsu, Takahiro

    1. Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan
      Taro Funakoshi, Takahiro Horimatsu, Michio Nakamura, Koichi Shiroshita, Koichi Suyama, Masashi Mukoyama, Takuro Mizukami, Tsutomu Sakurada, Eishi Baba, Kazuhiko Tsuruya, Akira Nozaki, Kensei Yahata, Yukinori Ozaki, Yoshifumi Ubara, Hisateru Yasui, Akihiro Yoshimoto, Shingo Fukuma, Naoya Kondo, Takeshi Matsubara, Kazuo Matsubara, Shunichi Fukuhara, Motoko Yanagita, Manabu Muto
  5. Horinouchi, Hidehito

    1. Circulating cell-free plasma tumour DNA shows a higher incidence of EGFR mutations in patients with extrathoracic disease progression
      Yoshitaka Seki, Yutaka Fujiwara, Takashi Kohno, Kazushi Yoshida, Yasushi Goto, Hidehito Horinouchi, Shintaro Kanda, Hiroshi Nokihara, Noboru Yamamoto, Kazuyoshi Kuwano, Yuichiro Ohe

I

  1. Ilbawi, André

    1. Global cancer control: responding to the growing burden, rising costs and inequalities in access
      Gerald W Prager, Sofia Braga, Branislav Bystricky, Camilla Qvortrup, Carmen Criscitiello, Ece Esin, Gabe S Sonke, Guillem Argilés Martínez, Jean-Sebastian Frenel, Michalis Karamouzis, Michiel Strijbos, Ozan Yazici, Paolo Bossi, Susana Banerjee, Teresa Troiani, Alexandru Eniu, Fortunato Ciardiello, Josep Tabernero, Christoph C Zielinski, Paolo G Casali, Fatima Cardoso, Jean-Yves Douillard, Svetlana Jezdic, Keith McGregor, Gracemarie Bricalli, Malvika Vyas, André Ilbawi
  2. Inoue, Akira

    1. Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations
      Satoshi Oizumi, Shunichi Sugawara, Koichi Minato, Toshiyuki Harada, Akira Inoue, Yuka Fujita, Makoto Maemondo, Satoshi Watanabe, Kazuhiko Ito, Akihiko Gemma, Yoshiki Demura, Shinichi Fukumoto, Hiroshi Isobe, Ichiro Kinoshita, Satoshi Morita, Kunihiko Kobayashi, Koichi Hagiwara, Keisuke Aiba, Toshihiro Nukiwa
  3. Isobe, Hiroshi

    1. Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations
      Satoshi Oizumi, Shunichi Sugawara, Koichi Minato, Toshiyuki Harada, Akira Inoue, Yuka Fujita, Makoto Maemondo, Satoshi Watanabe, Kazuhiko Ito, Akihiko Gemma, Yoshiki Demura, Shinichi Fukumoto, Hiroshi Isobe, Ichiro Kinoshita, Satoshi Morita, Kunihiko Kobayashi, Koichi Hagiwara, Keisuke Aiba, Toshihiro Nukiwa
  4. Ito, Kazuhiko

    1. Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations
      Satoshi Oizumi, Shunichi Sugawara, Koichi Minato, Toshiyuki Harada, Akira Inoue, Yuka Fujita, Makoto Maemondo, Satoshi Watanabe, Kazuhiko Ito, Akihiko Gemma, Yoshiki Demura, Shinichi Fukumoto, Hiroshi Isobe, Ichiro Kinoshita, Satoshi Morita, Kunihiko Kobayashi, Koichi Hagiwara, Keisuke Aiba, Toshihiro Nukiwa
  5. Iwata, Hiroji

    1. Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial
      Takayuki Ueno, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Takeharu Yamanaka, Hironobu Sasano, Masakazu Toi

J

  1. Jezdic, Svetlana

    1. Global cancer control: responding to the growing burden, rising costs and inequalities in access
      Gerald W Prager, Sofia Braga, Branislav Bystricky, Camilla Qvortrup, Carmen Criscitiello, Ece Esin, Gabe S Sonke, Guillem Argilés Martínez, Jean-Sebastian Frenel, Michalis Karamouzis, Michiel Strijbos, Ozan Yazici, Paolo Bossi, Susana Banerjee, Teresa Troiani, Alexandru Eniu, Fortunato Ciardiello, Josep Tabernero, Christoph C Zielinski, Paolo G Casali, Fatima Cardoso, Jean-Yves Douillard, Svetlana Jezdic, Keith McGregor, Gracemarie Bricalli, Malvika Vyas, André Ilbawi

K

  1. Kanda, Shintaro

    1. Circulating cell-free plasma tumour DNA shows a higher incidence of EGFR mutations in patients with extrathoracic disease progression
      Yoshitaka Seki, Yutaka Fujiwara, Takashi Kohno, Kazushi Yoshida, Yasushi Goto, Hidehito Horinouchi, Shintaro Kanda, Hiroshi Nokihara, Noboru Yamamoto, Kazuyoshi Kuwano, Yuichiro Ohe
  2. Karamouzis, Michalis

    1. Global cancer control: responding to the growing burden, rising costs and inequalities in access
      Gerald W Prager, Sofia Braga, Branislav Bystricky, Camilla Qvortrup, Carmen Criscitiello, Ece Esin, Gabe S Sonke, Guillem Argilés Martínez, Jean-Sebastian Frenel, Michalis Karamouzis, Michiel Strijbos, Ozan Yazici, Paolo Bossi, Susana Banerjee, Teresa Troiani, Alexandru Eniu, Fortunato Ciardiello, Josep Tabernero, Christoph C Zielinski, Paolo G Casali, Fatima Cardoso, Jean-Yves Douillard, Svetlana Jezdic, Keith McGregor, Gracemarie Bricalli, Malvika Vyas, André Ilbawi
  3. Karthaus, Meinolf

    1. Exploratory pooled analysis evaluating the effect of sequence of biological therapies on overall survival in patients with RAS wild-type metastatic colorectal carcinoma
      Marc Peeters, Frédéric Forget, Meinolf Karthaus, Manuel Valladares-Ayerbes, Alberto Zaniboni, Gaston Demonty, Xuesong Guan, Fernando Rivera
  4. Kinoshita, Ichiro

    1. Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations
      Satoshi Oizumi, Shunichi Sugawara, Koichi Minato, Toshiyuki Harada, Akira Inoue, Yuka Fujita, Makoto Maemondo, Satoshi Watanabe, Kazuhiko Ito, Akihiko Gemma, Yoshiki Demura, Shinichi Fukumoto, Hiroshi Isobe, Ichiro Kinoshita, Satoshi Morita, Kunihiko Kobayashi, Koichi Hagiwara, Keisuke Aiba, Toshihiro Nukiwa
  5. Kobayashi, Kunihiko

    1. Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations
      Satoshi Oizumi, Shunichi Sugawara, Koichi Minato, Toshiyuki Harada, Akira Inoue, Yuka Fujita, Makoto Maemondo, Satoshi Watanabe, Kazuhiko Ito, Akihiko Gemma, Yoshiki Demura, Shinichi Fukumoto, Hiroshi Isobe, Ichiro Kinoshita, Satoshi Morita, Kunihiko Kobayashi, Koichi Hagiwara, Keisuke Aiba, Toshihiro Nukiwa
  6. Kohno, Takashi

    1. Circulating cell-free plasma tumour DNA shows a higher incidence of EGFR mutations in patients with extrathoracic disease progression
      Yoshitaka Seki, Yutaka Fujiwara, Takashi Kohno, Kazushi Yoshida, Yasushi Goto, Hidehito Horinouchi, Shintaro Kanda, Hiroshi Nokihara, Noboru Yamamoto, Kazuyoshi Kuwano, Yuichiro Ohe
  7. Kondo, Naoya

    1. Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan
      Taro Funakoshi, Takahiro Horimatsu, Michio Nakamura, Koichi Shiroshita, Koichi Suyama, Masashi Mukoyama, Takuro Mizukami, Tsutomu Sakurada, Eishi Baba, Kazuhiko Tsuruya, Akira Nozaki, Kensei Yahata, Yukinori Ozaki, Yoshifumi Ubara, Hisateru Yasui, Akihiro Yoshimoto, Shingo Fukuma, Naoya Kondo, Takeshi Matsubara, Kazuo Matsubara, Shunichi Fukuhara, Motoko Yanagita, Manabu Muto
  8. Krendyukov, Andriy

    1. Extrapolation concept at work with biosimilar: a decade of experience in oncology
      Andriy Krendyukov, Martin Schiestl
  9. Kuroi, Katsumasa

    1. Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial
      Takayuki Ueno, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Takeharu Yamanaka, Hironobu Sasano, Masakazu Toi
  10. Kuwano, Kazuyoshi

    1. Circulating cell-free plasma tumour DNA shows a higher incidence of EGFR mutations in patients with extrathoracic disease progression
      Yoshitaka Seki, Yutaka Fujiwara, Takashi Kohno, Kazushi Yoshida, Yasushi Goto, Hidehito Horinouchi, Shintaro Kanda, Hiroshi Nokihara, Noboru Yamamoto, Kazuyoshi Kuwano, Yuichiro Ohe

L

  1. Larkin, James M

    1. Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanoma
      Kok Haw Jonathan Lim, Lavinia Spain, Claire Barker, Alexandros Georgiou, Gerard Walls, Martin Gore, Samra Turajlic, Ruth Board, James M Larkin, Paul Lorigan
  2. Lim, Kok Haw Jonathan

    1. Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanoma
      Kok Haw Jonathan Lim, Lavinia Spain, Claire Barker, Alexandros Georgiou, Gerard Walls, Martin Gore, Samra Turajlic, Ruth Board, James M Larkin, Paul Lorigan
  3. Lorigan, Paul

    1. Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanoma
      Kok Haw Jonathan Lim, Lavinia Spain, Claire Barker, Alexandros Georgiou, Gerard Walls, Martin Gore, Samra Turajlic, Ruth Board, James M Larkin, Paul Lorigan

M

  1. Maemondo, Makoto

    1. Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations
      Satoshi Oizumi, Shunichi Sugawara, Koichi Minato, Toshiyuki Harada, Akira Inoue, Yuka Fujita, Makoto Maemondo, Satoshi Watanabe, Kazuhiko Ito, Akihiko Gemma, Yoshiki Demura, Shinichi Fukumoto, Hiroshi Isobe, Ichiro Kinoshita, Satoshi Morita, Kunihiko Kobayashi, Koichi Hagiwara, Keisuke Aiba, Toshihiro Nukiwa
  2. Martínez, Guillem Argilés

    1. Global cancer control: responding to the growing burden, rising costs and inequalities in access
      Gerald W Prager, Sofia Braga, Branislav Bystricky, Camilla Qvortrup, Carmen Criscitiello, Ece Esin, Gabe S Sonke, Guillem Argilés Martínez, Jean-Sebastian Frenel, Michalis Karamouzis, Michiel Strijbos, Ozan Yazici, Paolo Bossi, Susana Banerjee, Teresa Troiani, Alexandru Eniu, Fortunato Ciardiello, Josep Tabernero, Christoph C Zielinski, Paolo G Casali, Fatima Cardoso, Jean-Yves Douillard, Svetlana Jezdic, Keith McGregor, Gracemarie Bricalli, Malvika Vyas, André Ilbawi
  3. Masuda, Norikazu

    1. Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial
      Takayuki Ueno, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Takeharu Yamanaka, Hironobu Sasano, Masakazu Toi
  4. Matsubara, Kazuo

    1. Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan
      Taro Funakoshi, Takahiro Horimatsu, Michio Nakamura, Koichi Shiroshita, Koichi Suyama, Masashi Mukoyama, Takuro Mizukami, Tsutomu Sakurada, Eishi Baba, Kazuhiko Tsuruya, Akira Nozaki, Kensei Yahata, Yukinori Ozaki, Yoshifumi Ubara, Hisateru Yasui, Akihiro Yoshimoto, Shingo Fukuma, Naoya Kondo, Takeshi Matsubara, Kazuo Matsubara, Shunichi Fukuhara, Motoko Yanagita, Manabu Muto
  5. Matsubara, Takeshi

    1. Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan
      Taro Funakoshi, Takahiro Horimatsu, Michio Nakamura, Koichi Shiroshita, Koichi Suyama, Masashi Mukoyama, Takuro Mizukami, Tsutomu Sakurada, Eishi Baba, Kazuhiko Tsuruya, Akira Nozaki, Kensei Yahata, Yukinori Ozaki, Yoshifumi Ubara, Hisateru Yasui, Akihiro Yoshimoto, Shingo Fukuma, Naoya Kondo, Takeshi Matsubara, Kazuo Matsubara, Shunichi Fukuhara, Motoko Yanagita, Manabu Muto
  6. McGregor, Keith

    1. Global cancer control: responding to the growing burden, rising costs and inequalities in access
      Gerald W Prager, Sofia Braga, Branislav Bystricky, Camilla Qvortrup, Carmen Criscitiello, Ece Esin, Gabe S Sonke, Guillem Argilés Martínez, Jean-Sebastian Frenel, Michalis Karamouzis, Michiel Strijbos, Ozan Yazici, Paolo Bossi, Susana Banerjee, Teresa Troiani, Alexandru Eniu, Fortunato Ciardiello, Josep Tabernero, Christoph C Zielinski, Paolo G Casali, Fatima Cardoso, Jean-Yves Douillard, Svetlana Jezdic, Keith McGregor, Gracemarie Bricalli, Malvika Vyas, André Ilbawi
  7. Minato, Koichi

    1. Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations
      Satoshi Oizumi, Shunichi Sugawara, Koichi Minato, Toshiyuki Harada, Akira Inoue, Yuka Fujita, Makoto Maemondo, Satoshi Watanabe, Kazuhiko Ito, Akihiko Gemma, Yoshiki Demura, Shinichi Fukumoto, Hiroshi Isobe, Ichiro Kinoshita, Satoshi Morita, Kunihiko Kobayashi, Koichi Hagiwara, Keisuke Aiba, Toshihiro Nukiwa
  8. Mizukami, Takuro

    1. Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan
      Taro Funakoshi, Takahiro Horimatsu, Michio Nakamura, Koichi Shiroshita, Koichi Suyama, Masashi Mukoyama, Takuro Mizukami, Tsutomu Sakurada, Eishi Baba, Kazuhiko Tsuruya, Akira Nozaki, Kensei Yahata, Yukinori Ozaki, Yoshifumi Ubara, Hisateru Yasui, Akihiro Yoshimoto, Shingo Fukuma, Naoya Kondo, Takeshi Matsubara, Kazuo Matsubara, Shunichi Fukuhara, Motoko Yanagita, Manabu Muto
  9. Moore, Kathleen N

    1. Phase I study of the investigational oral mTORC1/2 inhibitor sapanisertib (TAK-228): tolerability and food effects of a milled formulation in patients with advanced solid tumours
      Kathleen N Moore, Todd M Bauer, Gerald S Falchook, Swapan Chowdhury, Chirag Patel, Rachel Neuwirth, Aaron Enke, Fabian Zohren, Manish R Patel
  10. Morita, Satoshi

    1. Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations
      Satoshi Oizumi, Shunichi Sugawara, Koichi Minato, Toshiyuki Harada, Akira Inoue, Yuka Fujita, Makoto Maemondo, Satoshi Watanabe, Kazuhiko Ito, Akihiko Gemma, Yoshiki Demura, Shinichi Fukumoto, Hiroshi Isobe, Ichiro Kinoshita, Satoshi Morita, Kunihiko Kobayashi, Koichi Hagiwara, Keisuke Aiba, Toshihiro Nukiwa
  11. Mukoyama, Masashi

    1. Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan
      Taro Funakoshi, Takahiro Horimatsu, Michio Nakamura, Koichi Shiroshita, Koichi Suyama, Masashi Mukoyama, Takuro Mizukami, Tsutomu Sakurada, Eishi Baba, Kazuhiko Tsuruya, Akira Nozaki, Kensei Yahata, Yukinori Ozaki, Yoshifumi Ubara, Hisateru Yasui, Akihiro Yoshimoto, Shingo Fukuma, Naoya Kondo, Takeshi Matsubara, Kazuo Matsubara, Shunichi Fukuhara, Motoko Yanagita, Manabu Muto
  12. Muto, Manabu

    1. Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan
      Taro Funakoshi, Takahiro Horimatsu, Michio Nakamura, Koichi Shiroshita, Koichi Suyama, Masashi Mukoyama, Takuro Mizukami, Tsutomu Sakurada, Eishi Baba, Kazuhiko Tsuruya, Akira Nozaki, Kensei Yahata, Yukinori Ozaki, Yoshifumi Ubara, Hisateru Yasui, Akihiro Yoshimoto, Shingo Fukuma, Naoya Kondo, Takeshi Matsubara, Kazuo Matsubara, Shunichi Fukuhara, Motoko Yanagita, Manabu Muto

N

  1. Nakamura, Michio

    1. Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan
      Taro Funakoshi, Takahiro Horimatsu, Michio Nakamura, Koichi Shiroshita, Koichi Suyama, Masashi Mukoyama, Takuro Mizukami, Tsutomu Sakurada, Eishi Baba, Kazuhiko Tsuruya, Akira Nozaki, Kensei Yahata, Yukinori Ozaki, Yoshifumi Ubara, Hisateru Yasui, Akihiro Yoshimoto, Shingo Fukuma, Naoya Kondo, Takeshi Matsubara, Kazuo Matsubara, Shunichi Fukuhara, Motoko Yanagita, Manabu Muto
  2. Neuwirth, Rachel

    1. Phase I study of the investigational oral mTORC1/2 inhibitor sapanisertib (TAK-228): tolerability and food effects of a milled formulation in patients with advanced solid tumours
      Kathleen N Moore, Todd M Bauer, Gerald S Falchook, Swapan Chowdhury, Chirag Patel, Rachel Neuwirth, Aaron Enke, Fabian Zohren, Manish R Patel
  3. Nokihara, Hiroshi

    1. Circulating cell-free plasma tumour DNA shows a higher incidence of EGFR mutations in patients with extrathoracic disease progression
      Yoshitaka Seki, Yutaka Fujiwara, Takashi Kohno, Kazushi Yoshida, Yasushi Goto, Hidehito Horinouchi, Shintaro Kanda, Hiroshi Nokihara, Noboru Yamamoto, Kazuyoshi Kuwano, Yuichiro Ohe
  4. Nozaki, Akira

    1. Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan
      Taro Funakoshi, Takahiro Horimatsu, Michio Nakamura, Koichi Shiroshita, Koichi Suyama, Masashi Mukoyama, Takuro Mizukami, Tsutomu Sakurada, Eishi Baba, Kazuhiko Tsuruya, Akira Nozaki, Kensei Yahata, Yukinori Ozaki, Yoshifumi Ubara, Hisateru Yasui, Akihiro Yoshimoto, Shingo Fukuma, Naoya Kondo, Takeshi Matsubara, Kazuo Matsubara, Shunichi Fukuhara, Motoko Yanagita, Manabu Muto
  5. Nukiwa, Toshihiro

    1. Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations
      Satoshi Oizumi, Shunichi Sugawara, Koichi Minato, Toshiyuki Harada, Akira Inoue, Yuka Fujita, Makoto Maemondo, Satoshi Watanabe, Kazuhiko Ito, Akihiko Gemma, Yoshiki Demura, Shinichi Fukumoto, Hiroshi Isobe, Ichiro Kinoshita, Satoshi Morita, Kunihiko Kobayashi, Koichi Hagiwara, Keisuke Aiba, Toshihiro Nukiwa

O

  1. Ohe, Yuichiro

    1. Circulating cell-free plasma tumour DNA shows a higher incidence of EGFR mutations in patients with extrathoracic disease progression
      Yoshitaka Seki, Yutaka Fujiwara, Takashi Kohno, Kazushi Yoshida, Yasushi Goto, Hidehito Horinouchi, Shintaro Kanda, Hiroshi Nokihara, Noboru Yamamoto, Kazuyoshi Kuwano, Yuichiro Ohe
  2. Ohno, Shinji

    1. Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial
      Takayuki Ueno, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Takeharu Yamanaka, Hironobu Sasano, Masakazu Toi
  3. Oizumi, Satoshi

    1. Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations
      Satoshi Oizumi, Shunichi Sugawara, Koichi Minato, Toshiyuki Harada, Akira Inoue, Yuka Fujita, Makoto Maemondo, Satoshi Watanabe, Kazuhiko Ito, Akihiko Gemma, Yoshiki Demura, Shinichi Fukumoto, Hiroshi Isobe, Ichiro Kinoshita, Satoshi Morita, Kunihiko Kobayashi, Koichi Hagiwara, Keisuke Aiba, Toshihiro Nukiwa
  4. Ozaki, Yukinori

    1. Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan
      Taro Funakoshi, Takahiro Horimatsu, Michio Nakamura, Koichi Shiroshita, Koichi Suyama, Masashi Mukoyama, Takuro Mizukami, Tsutomu Sakurada, Eishi Baba, Kazuhiko Tsuruya, Akira Nozaki, Kensei Yahata, Yukinori Ozaki, Yoshifumi Ubara, Hisateru Yasui, Akihiro Yoshimoto, Shingo Fukuma, Naoya Kondo, Takeshi Matsubara, Kazuo Matsubara, Shunichi Fukuhara, Motoko Yanagita, Manabu Muto

P

  1. Patel, Chirag

    1. Phase I study of the investigational oral mTORC1/2 inhibitor sapanisertib (TAK-228): tolerability and food effects of a milled formulation in patients with advanced solid tumours
      Kathleen N Moore, Todd M Bauer, Gerald S Falchook, Swapan Chowdhury, Chirag Patel, Rachel Neuwirth, Aaron Enke, Fabian Zohren, Manish R Patel
  2. Patel, Manish R

    1. Phase I study of the investigational oral mTORC1/2 inhibitor sapanisertib (TAK-228): tolerability and food effects of a milled formulation in patients with advanced solid tumours
      Kathleen N Moore, Todd M Bauer, Gerald S Falchook, Swapan Chowdhury, Chirag Patel, Rachel Neuwirth, Aaron Enke, Fabian Zohren, Manish R Patel
  3. Peeters, Marc

    1. Exploratory pooled analysis evaluating the effect of sequence of biological therapies on overall survival in patients with RAS wild-type metastatic colorectal carcinoma
      Marc Peeters, Frédéric Forget, Meinolf Karthaus, Manuel Valladares-Ayerbes, Alberto Zaniboni, Gaston Demonty, Xuesong Guan, Fernando Rivera
  4. Pond, Gregory R

    1. Prognostic indices of inflammatory markers, cognitive function and fatigue for survival in patients with localised colorectal cancer
      Janette L Vardy, Haryana Mary Dhillon, Gregory R Pond, Corrinne Renton, Stephen J Clarke, Ian F Tannock
  5. Prager, Gerald W

    1. Global cancer control: responding to the growing burden, rising costs and inequalities in access
      Gerald W Prager, Sofia Braga, Branislav Bystricky, Camilla Qvortrup, Carmen Criscitiello, Ece Esin, Gabe S Sonke, Guillem Argilés Martínez, Jean-Sebastian Frenel, Michalis Karamouzis, Michiel Strijbos, Ozan Yazici, Paolo Bossi, Susana Banerjee, Teresa Troiani, Alexandru Eniu, Fortunato Ciardiello, Josep Tabernero, Christoph C Zielinski, Paolo G Casali, Fatima Cardoso, Jean-Yves Douillard, Svetlana Jezdic, Keith McGregor, Gracemarie Bricalli, Malvika Vyas, André Ilbawi

Q

  1. Qvortrup, Camilla

    1. Global cancer control: responding to the growing burden, rising costs and inequalities in access
      Gerald W Prager, Sofia Braga, Branislav Bystricky, Camilla Qvortrup, Carmen Criscitiello, Ece Esin, Gabe S Sonke, Guillem Argilés Martínez, Jean-Sebastian Frenel, Michalis Karamouzis, Michiel Strijbos, Ozan Yazici, Paolo Bossi, Susana Banerjee, Teresa Troiani, Alexandru Eniu, Fortunato Ciardiello, Josep Tabernero, Christoph C Zielinski, Paolo G Casali, Fatima Cardoso, Jean-Yves Douillard, Svetlana Jezdic, Keith McGregor, Gracemarie Bricalli, Malvika Vyas, André Ilbawi

R

  1. Renton, Corrinne

    1. Prognostic indices of inflammatory markers, cognitive function and fatigue for survival in patients with localised colorectal cancer
      Janette L Vardy, Haryana Mary Dhillon, Gregory R Pond, Corrinne Renton, Stephen J Clarke, Ian F Tannock
  2. Rivera, Fernando

    1. Exploratory pooled analysis evaluating the effect of sequence of biological therapies on overall survival in patients with RAS wild-type metastatic colorectal carcinoma
      Marc Peeters, Frédéric Forget, Meinolf Karthaus, Manuel Valladares-Ayerbes, Alberto Zaniboni, Gaston Demonty, Xuesong Guan, Fernando Rivera

S

  1. Saji, Shigehira

    1. Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial
      Takayuki Ueno, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Takeharu Yamanaka, Hironobu Sasano, Masakazu Toi
  2. Sakurada, Tsutomu

    1. Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan
      Taro Funakoshi, Takahiro Horimatsu, Michio Nakamura, Koichi Shiroshita, Koichi Suyama, Masashi Mukoyama, Takuro Mizukami, Tsutomu Sakurada, Eishi Baba, Kazuhiko Tsuruya, Akira Nozaki, Kensei Yahata, Yukinori Ozaki, Yoshifumi Ubara, Hisateru Yasui, Akihiro Yoshimoto, Shingo Fukuma, Naoya Kondo, Takeshi Matsubara, Kazuo Matsubara, Shunichi Fukuhara, Motoko Yanagita, Manabu Muto
  3. Salzberg, Marc

    1. Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas
      Walter Fiedler, Sara Cresta, Henning Schulze-Bergkamen, Sara De Dosso, Jens Weidmann, Anna Tessari, Hans Baumeister, Antje Danielczyk, Bruno Dietrich, Steffen Goletz, Alfredo Zurlo, Marc Salzberg, Cristiana Sessa, Luca Gianni
  4. Sasano, Hironobu

    1. Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial
      Takayuki Ueno, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Takeharu Yamanaka, Hironobu Sasano, Masakazu Toi
  5. Sato, Nobuaki

    1. Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial
      Takayuki Ueno, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Takeharu Yamanaka, Hironobu Sasano, Masakazu Toi
  6. Schiestl, Martin

    1. Extrapolation concept at work with biosimilar: a decade of experience in oncology
      Andriy Krendyukov, Martin Schiestl
  7. Schulze-Bergkamen, Henning

    1. Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas
      Walter Fiedler, Sara Cresta, Henning Schulze-Bergkamen, Sara De Dosso, Jens Weidmann, Anna Tessari, Hans Baumeister, Antje Danielczyk, Bruno Dietrich, Steffen Goletz, Alfredo Zurlo, Marc Salzberg, Cristiana Sessa, Luca Gianni
  8. Seki, Yoshitaka

    1. Circulating cell-free plasma tumour DNA shows a higher incidence of EGFR mutations in patients with extrathoracic disease progression
      Yoshitaka Seki, Yutaka Fujiwara, Takashi Kohno, Kazushi Yoshida, Yasushi Goto, Hidehito Horinouchi, Shintaro Kanda, Hiroshi Nokihara, Noboru Yamamoto, Kazuyoshi Kuwano, Yuichiro Ohe
  9. Sessa, Cristiana

    1. Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas
      Walter Fiedler, Sara Cresta, Henning Schulze-Bergkamen, Sara De Dosso, Jens Weidmann, Anna Tessari, Hans Baumeister, Antje Danielczyk, Bruno Dietrich, Steffen Goletz, Alfredo Zurlo, Marc Salzberg, Cristiana Sessa, Luca Gianni
  10. Shiroshita, Koichi

    1. Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan
      Taro Funakoshi, Takahiro Horimatsu, Michio Nakamura, Koichi Shiroshita, Koichi Suyama, Masashi Mukoyama, Takuro Mizukami, Tsutomu Sakurada, Eishi Baba, Kazuhiko Tsuruya, Akira Nozaki, Kensei Yahata, Yukinori Ozaki, Yoshifumi Ubara, Hisateru Yasui, Akihiro Yoshimoto, Shingo Fukuma, Naoya Kondo, Takeshi Matsubara, Kazuo Matsubara, Shunichi Fukuhara, Motoko Yanagita, Manabu Muto
  11. Sonke, Gabe S

    1. Global cancer control: responding to the growing burden, rising costs and inequalities in access
      Gerald W Prager, Sofia Braga, Branislav Bystricky, Camilla Qvortrup, Carmen Criscitiello, Ece Esin, Gabe S Sonke, Guillem Argilés Martínez, Jean-Sebastian Frenel, Michalis Karamouzis, Michiel Strijbos, Ozan Yazici, Paolo Bossi, Susana Banerjee, Teresa Troiani, Alexandru Eniu, Fortunato Ciardiello, Josep Tabernero, Christoph C Zielinski, Paolo G Casali, Fatima Cardoso, Jean-Yves Douillard, Svetlana Jezdic, Keith McGregor, Gracemarie Bricalli, Malvika Vyas, André Ilbawi
  12. Spain, Lavinia

    1. Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanoma
      Kok Haw Jonathan Lim, Lavinia Spain, Claire Barker, Alexandros Georgiou, Gerard Walls, Martin Gore, Samra Turajlic, Ruth Board, James M Larkin, Paul Lorigan
  13. Strijbos, Michiel

    1. Global cancer control: responding to the growing burden, rising costs and inequalities in access
      Gerald W Prager, Sofia Braga, Branislav Bystricky, Camilla Qvortrup, Carmen Criscitiello, Ece Esin, Gabe S Sonke, Guillem Argilés Martínez, Jean-Sebastian Frenel, Michalis Karamouzis, Michiel Strijbos, Ozan Yazici, Paolo Bossi, Susana Banerjee, Teresa Troiani, Alexandru Eniu, Fortunato Ciardiello, Josep Tabernero, Christoph C Zielinski, Paolo G Casali, Fatima Cardoso, Jean-Yves Douillard, Svetlana Jezdic, Keith McGregor, Gracemarie Bricalli, Malvika Vyas, André Ilbawi
  14. Sugawara, Shunichi

    1. Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations
      Satoshi Oizumi, Shunichi Sugawara, Koichi Minato, Toshiyuki Harada, Akira Inoue, Yuka Fujita, Makoto Maemondo, Satoshi Watanabe, Kazuhiko Ito, Akihiko Gemma, Yoshiki Demura, Shinichi Fukumoto, Hiroshi Isobe, Ichiro Kinoshita, Satoshi Morita, Kunihiko Kobayashi, Koichi Hagiwara, Keisuke Aiba, Toshihiro Nukiwa
  15. Suyama, Koichi

    1. Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan
      Taro Funakoshi, Takahiro Horimatsu, Michio Nakamura, Koichi Shiroshita, Koichi Suyama, Masashi Mukoyama, Takuro Mizukami, Tsutomu Sakurada, Eishi Baba, Kazuhiko Tsuruya, Akira Nozaki, Kensei Yahata, Yukinori Ozaki, Yoshifumi Ubara, Hisateru Yasui, Akihiro Yoshimoto, Shingo Fukuma, Naoya Kondo, Takeshi Matsubara, Kazuo Matsubara, Shunichi Fukuhara, Motoko Yanagita, Manabu Muto

T

  1. Tabernero, Josep

    1. Global cancer control: responding to the growing burden, rising costs and inequalities in access
      Gerald W Prager, Sofia Braga, Branislav Bystricky, Camilla Qvortrup, Carmen Criscitiello, Ece Esin, Gabe S Sonke, Guillem Argilés Martínez, Jean-Sebastian Frenel, Michalis Karamouzis, Michiel Strijbos, Ozan Yazici, Paolo Bossi, Susana Banerjee, Teresa Troiani, Alexandru Eniu, Fortunato Ciardiello, Josep Tabernero, Christoph C Zielinski, Paolo G Casali, Fatima Cardoso, Jean-Yves Douillard, Svetlana Jezdic, Keith McGregor, Gracemarie Bricalli, Malvika Vyas, André Ilbawi
  2. Takei, Hiroyuki

    1. Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial
      Takayuki Ueno, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Takeharu Yamanaka, Hironobu Sasano, Masakazu Toi
  3. Tannock, Ian F

    1. Prognostic indices of inflammatory markers, cognitive function and fatigue for survival in patients with localised colorectal cancer
      Janette L Vardy, Haryana Mary Dhillon, Gregory R Pond, Corrinne Renton, Stephen J Clarke, Ian F Tannock
  4. Tessari, Anna

    1. Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas
      Walter Fiedler, Sara Cresta, Henning Schulze-Bergkamen, Sara De Dosso, Jens Weidmann, Anna Tessari, Hans Baumeister, Antje Danielczyk, Bruno Dietrich, Steffen Goletz, Alfredo Zurlo, Marc Salzberg, Cristiana Sessa, Luca Gianni
  5. Toi, Masakazu

    1. Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial
      Takayuki Ueno, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Takeharu Yamanaka, Hironobu Sasano, Masakazu Toi
  6. Troiani, Teresa

    1. Global cancer control: responding to the growing burden, rising costs and inequalities in access
      Gerald W Prager, Sofia Braga, Branislav Bystricky, Camilla Qvortrup, Carmen Criscitiello, Ece Esin, Gabe S Sonke, Guillem Argilés Martínez, Jean-Sebastian Frenel, Michalis Karamouzis, Michiel Strijbos, Ozan Yazici, Paolo Bossi, Susana Banerjee, Teresa Troiani, Alexandru Eniu, Fortunato Ciardiello, Josep Tabernero, Christoph C Zielinski, Paolo G Casali, Fatima Cardoso, Jean-Yves Douillard, Svetlana Jezdic, Keith McGregor, Gracemarie Bricalli, Malvika Vyas, André Ilbawi
  7. Tsuruya, Kazuhiko

    1. Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan
      Taro Funakoshi, Takahiro Horimatsu, Michio Nakamura, Koichi Shiroshita, Koichi Suyama, Masashi Mukoyama, Takuro Mizukami, Tsutomu Sakurada, Eishi Baba, Kazuhiko Tsuruya, Akira Nozaki, Kensei Yahata, Yukinori Ozaki, Yoshifumi Ubara, Hisateru Yasui, Akihiro Yoshimoto, Shingo Fukuma, Naoya Kondo, Takeshi Matsubara, Kazuo Matsubara, Shunichi Fukuhara, Motoko Yanagita, Manabu Muto
  8. Turajlic, Samra

    1. Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanoma
      Kok Haw Jonathan Lim, Lavinia Spain, Claire Barker, Alexandros Georgiou, Gerard Walls, Martin Gore, Samra Turajlic, Ruth Board, James M Larkin, Paul Lorigan

U

  1. Ubara, Yoshifumi

    1. Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan
      Taro Funakoshi, Takahiro Horimatsu, Michio Nakamura, Koichi Shiroshita, Koichi Suyama, Masashi Mukoyama, Takuro Mizukami, Tsutomu Sakurada, Eishi Baba, Kazuhiko Tsuruya, Akira Nozaki, Kensei Yahata, Yukinori Ozaki, Yoshifumi Ubara, Hisateru Yasui, Akihiro Yoshimoto, Shingo Fukuma, Naoya Kondo, Takeshi Matsubara, Kazuo Matsubara, Shunichi Fukuhara, Motoko Yanagita, Manabu Muto
  2. Ueno, Takayuki

    1. Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial
      Takayuki Ueno, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Takeharu Yamanaka, Hironobu Sasano, Masakazu Toi

V

  1. Valladares-Ayerbes, Manuel

    1. Exploratory pooled analysis evaluating the effect of sequence of biological therapies on overall survival in patients with RAS wild-type metastatic colorectal carcinoma
      Marc Peeters, Frédéric Forget, Meinolf Karthaus, Manuel Valladares-Ayerbes, Alberto Zaniboni, Gaston Demonty, Xuesong Guan, Fernando Rivera
  2. Vardy, Janette L

    1. Prognostic indices of inflammatory markers, cognitive function and fatigue for survival in patients with localised colorectal cancer
      Janette L Vardy, Haryana Mary Dhillon, Gregory R Pond, Corrinne Renton, Stephen J Clarke, Ian F Tannock
  3. Vyas, Malvika

    1. Global cancer control: responding to the growing burden, rising costs and inequalities in access
      Gerald W Prager, Sofia Braga, Branislav Bystricky, Camilla Qvortrup, Carmen Criscitiello, Ece Esin, Gabe S Sonke, Guillem Argilés Martínez, Jean-Sebastian Frenel, Michalis Karamouzis, Michiel Strijbos, Ozan Yazici, Paolo Bossi, Susana Banerjee, Teresa Troiani, Alexandru Eniu, Fortunato Ciardiello, Josep Tabernero, Christoph C Zielinski, Paolo G Casali, Fatima Cardoso, Jean-Yves Douillard, Svetlana Jezdic, Keith McGregor, Gracemarie Bricalli, Malvika Vyas, André Ilbawi

W

  1. Walls, Gerard

    1. Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanoma
      Kok Haw Jonathan Lim, Lavinia Spain, Claire Barker, Alexandros Georgiou, Gerard Walls, Martin Gore, Samra Turajlic, Ruth Board, James M Larkin, Paul Lorigan
  2. Watanabe, Satoshi

    1. Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations
      Satoshi Oizumi, Shunichi Sugawara, Koichi Minato, Toshiyuki Harada, Akira Inoue, Yuka Fujita, Makoto Maemondo, Satoshi Watanabe, Kazuhiko Ito, Akihiko Gemma, Yoshiki Demura, Shinichi Fukumoto, Hiroshi Isobe, Ichiro Kinoshita, Satoshi Morita, Kunihiko Kobayashi, Koichi Hagiwara, Keisuke Aiba, Toshihiro Nukiwa
  3. Weidmann, Jens

    1. Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas
      Walter Fiedler, Sara Cresta, Henning Schulze-Bergkamen, Sara De Dosso, Jens Weidmann, Anna Tessari, Hans Baumeister, Antje Danielczyk, Bruno Dietrich, Steffen Goletz, Alfredo Zurlo, Marc Salzberg, Cristiana Sessa, Luca Gianni

Y

  1. Yahata, Kensei

    1. Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan
      Taro Funakoshi, Takahiro Horimatsu, Michio Nakamura, Koichi Shiroshita, Koichi Suyama, Masashi Mukoyama, Takuro Mizukami, Tsutomu Sakurada, Eishi Baba, Kazuhiko Tsuruya, Akira Nozaki, Kensei Yahata, Yukinori Ozaki, Yoshifumi Ubara, Hisateru Yasui, Akihiro Yoshimoto, Shingo Fukuma, Naoya Kondo, Takeshi Matsubara, Kazuo Matsubara, Shunichi Fukuhara, Motoko Yanagita, Manabu Muto
  2. Yamamoto, Noboru

    1. Circulating cell-free plasma tumour DNA shows a higher incidence of EGFR mutations in patients with extrathoracic disease progression
      Yoshitaka Seki, Yutaka Fujiwara, Takashi Kohno, Kazushi Yoshida, Yasushi Goto, Hidehito Horinouchi, Shintaro Kanda, Hiroshi Nokihara, Noboru Yamamoto, Kazuyoshi Kuwano, Yuichiro Ohe
  3. Yamamoto, Yutaka

    1. Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial
      Takayuki Ueno, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Takeharu Yamanaka, Hironobu Sasano, Masakazu Toi
  4. Yamanaka, Takeharu

    1. Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial
      Takayuki Ueno, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Takeharu Yamanaka, Hironobu Sasano, Masakazu Toi
  5. Yamashita, Hiroko

    1. Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial
      Takayuki Ueno, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Takeharu Yamanaka, Hironobu Sasano, Masakazu Toi
  6. Yanagita, Motoko

    1. Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan
      Taro Funakoshi, Takahiro Horimatsu, Michio Nakamura, Koichi Shiroshita, Koichi Suyama, Masashi Mukoyama, Takuro Mizukami, Tsutomu Sakurada, Eishi Baba, Kazuhiko Tsuruya, Akira Nozaki, Kensei Yahata, Yukinori Ozaki, Yoshifumi Ubara, Hisateru Yasui, Akihiro Yoshimoto, Shingo Fukuma, Naoya Kondo, Takeshi Matsubara, Kazuo Matsubara, Shunichi Fukuhara, Motoko Yanagita, Manabu Muto
  7. Yasui, Hisateru

    1. Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan
      Taro Funakoshi, Takahiro Horimatsu, Michio Nakamura, Koichi Shiroshita, Koichi Suyama, Masashi Mukoyama, Takuro Mizukami, Tsutomu Sakurada, Eishi Baba, Kazuhiko Tsuruya, Akira Nozaki, Kensei Yahata, Yukinori Ozaki, Yoshifumi Ubara, Hisateru Yasui, Akihiro Yoshimoto, Shingo Fukuma, Naoya Kondo, Takeshi Matsubara, Kazuo Matsubara, Shunichi Fukuhara, Motoko Yanagita, Manabu Muto
  8. Yazici, Ozan

    1. Global cancer control: responding to the growing burden, rising costs and inequalities in access
      Gerald W Prager, Sofia Braga, Branislav Bystricky, Camilla Qvortrup, Carmen Criscitiello, Ece Esin, Gabe S Sonke, Guillem Argilés Martínez, Jean-Sebastian Frenel, Michalis Karamouzis, Michiel Strijbos, Ozan Yazici, Paolo Bossi, Susana Banerjee, Teresa Troiani, Alexandru Eniu, Fortunato Ciardiello, Josep Tabernero, Christoph C Zielinski, Paolo G Casali, Fatima Cardoso, Jean-Yves Douillard, Svetlana Jezdic, Keith McGregor, Gracemarie Bricalli, Malvika Vyas, André Ilbawi
  9. Yoshida, Kazushi

    1. Circulating cell-free plasma tumour DNA shows a higher incidence of EGFR mutations in patients with extrathoracic disease progression
      Yoshitaka Seki, Yutaka Fujiwara, Takashi Kohno, Kazushi Yoshida, Yasushi Goto, Hidehito Horinouchi, Shintaro Kanda, Hiroshi Nokihara, Noboru Yamamoto, Kazuyoshi Kuwano, Yuichiro Ohe
  10. Yoshimoto, Akihiro

    1. Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan
      Taro Funakoshi, Takahiro Horimatsu, Michio Nakamura, Koichi Shiroshita, Koichi Suyama, Masashi Mukoyama, Takuro Mizukami, Tsutomu Sakurada, Eishi Baba, Kazuhiko Tsuruya, Akira Nozaki, Kensei Yahata, Yukinori Ozaki, Yoshifumi Ubara, Hisateru Yasui, Akihiro Yoshimoto, Shingo Fukuma, Naoya Kondo, Takeshi Matsubara, Kazuo Matsubara, Shunichi Fukuhara, Motoko Yanagita, Manabu Muto

Z

  1. Zaniboni, Alberto

    1. Exploratory pooled analysis evaluating the effect of sequence of biological therapies on overall survival in patients with RAS wild-type metastatic colorectal carcinoma
      Marc Peeters, Frédéric Forget, Meinolf Karthaus, Manuel Valladares-Ayerbes, Alberto Zaniboni, Gaston Demonty, Xuesong Guan, Fernando Rivera
  2. Zielinski, Christoph C

    1. Global cancer control: responding to the growing burden, rising costs and inequalities in access
      Gerald W Prager, Sofia Braga, Branislav Bystricky, Camilla Qvortrup, Carmen Criscitiello, Ece Esin, Gabe S Sonke, Guillem Argilés Martínez, Jean-Sebastian Frenel, Michalis Karamouzis, Michiel Strijbos, Ozan Yazici, Paolo Bossi, Susana Banerjee, Teresa Troiani, Alexandru Eniu, Fortunato Ciardiello, Josep Tabernero, Christoph C Zielinski, Paolo G Casali, Fatima Cardoso, Jean-Yves Douillard, Svetlana Jezdic, Keith McGregor, Gracemarie Bricalli, Malvika Vyas, André Ilbawi
  3. Zohren, Fabian

    1. Phase I study of the investigational oral mTORC1/2 inhibitor sapanisertib (TAK-228): tolerability and food effects of a milled formulation in patients with advanced solid tumours
      Kathleen N Moore, Todd M Bauer, Gerald S Falchook, Swapan Chowdhury, Chirag Patel, Rachel Neuwirth, Aaron Enke, Fabian Zohren, Manish R Patel
  4. Zurlo, Alfredo

    1. Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas
      Walter Fiedler, Sara Cresta, Henning Schulze-Bergkamen, Sara De Dosso, Jens Weidmann, Anna Tessari, Hans Baumeister, Antje Danielczyk, Bruno Dietrich, Steffen Goletz, Alfredo Zurlo, Marc Salzberg, Cristiana Sessa, Luca Gianni